Surprisingly, increased levels of ABC transporters from non-multidrug-related subfamily A (ABCA1, ABCA6, ABCA8, and ABCA9) in primary tumours were statistically significantly associated with reduced survival in ovarian cancer patients [37]. The gene discussed is ABCG2; the disease is ovarian carcinoma.